New MS pill aims to outperform standard treatment in major global trial
NCT ID NCT05156281
Summary
This large Phase 3 study is testing whether a new oral drug called remibrutinib works better and is as safe as an existing standard oral medication (teriflunomide) for adults with relapsing multiple sclerosis (RMS). About 1011 participants will take one of the two drugs for up to 30 months, with many continuing on remibrutinib for up to 5 more years. The main goal is to see which drug is more effective at reducing the annual rate of MS relapses and slowing disability progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advent Health Orlando
Orlando, Florida, 32803, United States
-
Aqualane Clinical Research
Naples, Florida, 34105, United States
-
Ascension St Francis Center
Milwaukee, Wisconsin, 53215, United States
-
Baptist Physicians Lexington
Nicholasville, Kentucky, 40356, United States
-
Baylor Scott and White
Temple, Texas, 76508, United States
-
Brain and Spine Institute
Port Orange, Florida, 32127, United States
-
CU Anschutz Med Campus
Aurora, Colorado, 80045, United States
-
Caribbean Center for Clinical Research, Inc
Guaynabo, 00968, Puerto Rico
-
Clinre Comprehensive Neurology
Frederick, Maryland, 21702, United States
-
Colorado Neurological Research PC
Denver, Colorado, 80210, United States
-
Conquest Research
Winter Park, Florida, 32789, United States
-
Ctr for Neurology and Spine
Phoenix, Arizona, 85018, United States
-
Elligo Health Research
Crab Orchard, West Virginia, 25827, United States
-
Emerald Coast Neurology
Pensacola, Florida, 32514, United States
-
Gables Neurology
Miami, Florida, 33133, United States
-
Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Georgetown University Hospital Research
Washington D.C., District of Columbia, 20007, United States
-
Humanity Clinical Research
Pembroke Pines, Florida, 33024, United States
-
Kansas City VA Medical Center
Kansas City, Missouri, 64128, United States
-
Lone Star Neurology
Frisco, Texas, 75035, United States
-
Lonestar Neurology of San Antonio
San Antonio, Texas, 78258, United States
-
Med Research Inc
El Paso, Texas, 79935, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Memorial Healthcare System
Hollywood, Florida, 33021, United States
-
Methodist Neuroscience Institute
Merrillville, Indiana, 46410, United States
-
Metrolina Neurological Associates PA
Old Point Station, South Carolina, 29707, United States
-
Neurology Associates PA
Maitland, Florida, 32751, United States
-
Neurology Consultants Of Dallas PA
Dallas, Texas, 75231, United States
-
Neurology Diagnostics Inc
Dayton, Ohio, 45408, United States
-
New England Institute for Clinical Research
Stamford, Connecticut, 06905, United States
-
Nova Clinical Research LLC
Bradenton, Florida, 34209, United States
-
Novartis Investigative Site
Bombal, Mendoza Province, M5500DXO, Argentina
-
Novartis Investigative Site
Rosario, Santa Fe Province, S2000BZL, Argentina
-
Novartis Investigative Site
Rosario, Santa Fe Province, S2000DSW, Argentina
-
Novartis Investigative Site
San Miguel de, Tucumán Province, T4000, Argentina
-
Novartis Investigative Site
Buenos Aires, C1012AAR, Argentina
-
Novartis Investigative Site
CABA, C1181ACH, Argentina
-
Novartis Investigative Site
Córdoba, X5004CDT, Argentina
-
Novartis Investigative Site
Vitória, Espírito Santo, 29055-450, Brazil
-
Novartis Investigative Site
Brasília, Federal District, 70200-730, Brazil
-
Novartis Investigative Site
Curitiba, Paraná, 81210-310, Brazil
-
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, 90430-001, Brazil
-
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, 90560-032, Brazil
-
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, 90620-130, Brazil
-
Novartis Investigative Site
Joinville, Santa Catarina, 89202-165, Brazil
-
Novartis Investigative Site
São Paulo, 01240-020, Brazil
-
Novartis Investigative Site
Plovdiv, 4002, Bulgaria
-
Novartis Investigative Site
Sofia, 1309, Bulgaria
-
Novartis Investigative Site
Sofia, 1407, Bulgaria
-
Novartis Investigative Site
Sofia, 1431, Bulgaria
-
Novartis Investigative Site
Edmonton, Alberta, T6G 2B7, Canada
-
Novartis Investigative Site
Burnaby, British Columbia, V5G 2X6, Canada
-
Novartis Investigative Site
Halifax, Nova Scotia, B3H 4K4, Canada
-
Novartis Investigative Site
Ottawa, Ontario, K1H 8L6, Canada
-
Novartis Investigative Site
Lévis, Quebec, G6W 0M5, Canada
-
Novartis Investigative Site
Montreal, Quebec, H4A 3T2, Canada
-
Novartis Investigative Site
Québec, Quebec, G1J 1Z4, Canada
-
Novartis Investigative Site
Saint-Jérôme, Quebec, J7Z 5T3, Canada
-
Novartis Investigative Site
Wuhan, Hubei, 430030, China
-
Novartis Investigative Site
Wuhan, Hubei, 430060, China
-
Novartis Investigative Site
Nanjing, Jiangsu, 210029, China
-
Novartis Investigative Site
Yinchuan, Ningxia, 750004, China
-
Novartis Investigative Site
Taiyuan, Shanxi, 030001, China
-
Novartis Investigative Site
Hangzhou, Zhejiang, 310006, China
-
Novartis Investigative Site
Hangzhou, Zhejiang, 310016, China
-
Novartis Investigative Site
Wenzhou, Zhejiang, 325000, China
-
Novartis Investigative Site
Beijing, 100034, China
-
Novartis Investigative Site
Shanghai, 200025, China
-
Novartis Investigative Site
Shanghai, 200040, China
-
Novartis Investigative Site
Split, HRV, 21000, Croatia
-
Novartis Investigative Site
Varaždin, HRV, 42000, Croatia
-
Novartis Investigative Site
Vukovar, 32000, Croatia
-
Novartis Investigative Site
Zagreb, 10000, Croatia
-
Novartis Investigative Site
Brno, 602 00, Czechia
-
Novartis Investigative Site
Hradec Králové, 500 05, Czechia
-
Novartis Investigative Site
Teplice, 415 29, Czechia
-
Novartis Investigative Site
Tallinn, 11315, Estonia
-
Novartis Investigative Site
Tartu, 50406, Estonia
-
Novartis Investigative Site
Limoges, Haute Vienne, 87000, France
-
Novartis Investigative Site
Toulon, Val De Marne, 83800, France
-
Novartis Investigative Site
Caen, 14033, France
-
Novartis Investigative Site
Clermont-Ferrand, 63003, France
-
Novartis Investigative Site
Dijon, 21000, France
-
Novartis Investigative Site
Gonesse, 95500, France
-
Novartis Investigative Site
Grenoble, 38043, France
-
Novartis Investigative Site
Lille, 59000, France
-
Novartis Investigative Site
Lille, 59037, France
-
Novartis Investigative Site
Nice, 06001, France
-
Novartis Investigative Site
Nîmes, 30029, France
-
Novartis Investigative Site
Poissy, 78303, France
-
Novartis Investigative Site
Toulouse, 31059, France
-
Novartis Investigative Site
Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
-
Novartis Investigative Site
Essen, 45147, Germany
-
Novartis Investigative Site
Hamburg, 22179, Germany
-
Novartis Investigative Site
Ulm, 89073, Germany
-
Novartis Investigative Site
Athens, 115 28, Greece
-
Novartis Investigative Site
Athens, 11526, Greece
-
Novartis Investigative Site
Chaïdári, 124 62, Greece
-
Novartis Investigative Site
Ioannina, 455 00, Greece
-
Novartis Investigative Site
Larissa, 411 10, Greece
-
Novartis Investigative Site
Thessaloniki, 53246, Greece
-
Novartis Investigative Site
Thessaloniki, 54636, Greece
-
Novartis Investigative Site
Kochi, Kerala, 682025, India
-
Novartis Investigative Site
Pune, Maharashtra, 411013, India
-
Novartis Investigative Site
New Delhi, National Capital Territory of Delhi, 110060, India
-
Novartis Investigative Site
Amritsar, Punjab, 143006, India
-
Novartis Investigative Site
Hyderabad, Telangana, 500082, India
-
Novartis Investigative Site
Lucknow, Uttar Pradesh, 226007, India
-
Novartis Investigative Site
Kolkata, West Bengal, 700017, India
-
Novartis Investigative Site
Brindisi, BR, 72100, Italy
-
Novartis Investigative Site
Foggia, FG, 71122, Italy
-
Novartis Investigative Site
Pozzilli, IS, 86077, Italy
-
Novartis Investigative Site
Messina, ME, 98124, Italy
-
Novartis Investigative Site
Modena, MO, 41126, Italy
-
Novartis Investigative Site
Pavia, PV, 27100, Italy
-
Novartis Investigative Site
Orbassano, TO, 10043, Italy
-
Novartis Investigative Site
Naples, 80138, Italy
-
Novartis Investigative Site
Nagoya, Aichi-ken, 4668560, Japan
-
Novartis Investigative Site
Ichihara, Chiba, 2990111, Japan
-
Novartis Investigative Site
Sapporo, Hokkaido, 0630005, Japan
-
Novartis Investigative Site
Nishinomiya, Hyōgo, 663 8501, Japan
-
Novartis Investigative Site
Isehara, Kanagawa, 259-1193, Japan
-
Novartis Investigative Site
Sagamihara, Kanagawa, 252-0375, Japan
-
Novartis Investigative Site
Sendai, Miyagi, 9838512, Japan
-
Novartis Investigative Site
Kashihara, Nara, 634 8522, Japan
-
Novartis Investigative Site
Moriguchi, Osaka, 570-8507, Japan
-
Novartis Investigative Site
Suita, Osaka, 5650871, Japan
-
Novartis Investigative Site
Higashi-Matsuyama, Saitama, 355-0005, Japan
-
Novartis Investigative Site
Itabashi-ku, Tokyo, 1738610, Japan
-
Novartis Investigative Site
Kodaira, Tokyo, 187-8551, Japan
-
Novartis Investigative Site
Shinjuku Ku, Tokyo, 160-0023, Japan
-
Novartis Investigative Site
Shinjuku Ku, Tokyo, 1628666, Japan
-
Novartis Investigative Site
Shinjuku-ku, Tokyo, 1608582, Japan
-
Novartis Investigative Site
Chiba, 2608677, Japan
-
Novartis Investigative Site
Fukuoka, 810-0022, Japan
-
Novartis Investigative Site
Fukuoka, 8128582, Japan
-
Novartis Investigative Site
Kobe, 650-0017, Japan
-
Novartis Investigative Site
Kyoto, 616-8255, Japan
-
Novartis Investigative Site
Niigata, 9518520, Japan
-
Novartis Investigative Site
Mexico City, Mexico City, 06700, Mexico
-
Novartis Investigative Site
Chihuahua City, 31203, Mexico
-
Novartis Investigative Site
Mexico City, 14050, Mexico
-
Novartis Investigative Site
Querétaro, 76070, Mexico
-
Novartis Investigative Site
Plewiska, Poznan, 62-064, Poland
-
Novartis Investigative Site
Bialystok, 15-704, Poland
-
Novartis Investigative Site
Glogow Wielkopolski, 36-060, Poland
-
Novartis Investigative Site
Katowice, 40-081, Poland
-
Novartis Investigative Site
Katowice, 40-571, Poland
-
Novartis Investigative Site
Katowice, 40-686, Poland
-
Novartis Investigative Site
Katowice, 40-689, Poland
-
Novartis Investigative Site
Lublin, 20-701, Poland
-
Novartis Investigative Site
Wroclaw, 51-685, Poland
-
Novartis Investigative Site
Zabrze, 41-800, Poland
-
Novartis Investigative Site
Braga, 4710243, Portugal
-
Novartis Investigative Site
Coimbra, 3004-561, Portugal
-
Novartis Investigative Site
Leiria, 2410-197, Portugal
-
Novartis Investigative Site
Lisbon, 1169-050, Portugal
-
Novartis Investigative Site
Lisbon, 1649-035, Portugal
-
Novartis Investigative Site
Matosinhos Municipality, 4454-513, Portugal
-
Novartis Investigative Site
Santa Maria da Feira, 4520-211, Portugal
-
Novartis Investigative Site
Brasov, ROM, 500123, Romania
-
Novartis Investigative Site
Constanța, ROM, 900123, Romania
-
Novartis Investigative Site
Campulung Muscel, 115100, Romania
-
Novartis Investigative Site
Constanța, 900591, Romania
-
Novartis Investigative Site
Banská Bystrica, 974 04, Slovakia
-
Novartis Investigative Site
Banská Bystrica, 975 17, Slovakia
-
Novartis Investigative Site
Bratislava, 833 05, Slovakia
-
Novartis Investigative Site
Celje, 3000, Slovenia
-
Novartis Investigative Site
Ljubljana, 1000, Slovenia
-
Novartis Investigative Site
Maribor, 2000, Slovenia
-
Novartis Investigative Site
Bloemfontein, Free State, 9301, South Africa
-
Novartis Investigative Site
Pretoria, 0041, South Africa
-
Novartis Investigative Site
Rosebank, 2196, South Africa
-
Novartis Investigative Site
Santiago Compostela, A Coruna, 15706, Spain
-
Novartis Investigative Site
Vitoria-Gasteiz, Araba, 01009, Spain
-
Novartis Investigative Site
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
-
Novartis Investigative Site
Albacete, Castille-La Mancha, 02006, Spain
-
Novartis Investigative Site
Barcelona, Catalonia, 08003, Spain
-
Novartis Investigative Site
Logroño, La Rioja, 26006, Spain
-
Novartis Investigative Site
Pozuelo de Alarcón, Madrid, 28223, Spain
-
Novartis Investigative Site
Torrejón de Ardoz, Madrid, 28850, Spain
-
Novartis Investigative Site
Gijón, Principality of Asturias, 33394, Spain
-
Novartis Investigative Site
Valencia, Valencia, 46017, Spain
-
Novartis Investigative Site
Barcelona, 08041, Spain
-
Novartis Investigative Site
Lleida, 25198, Spain
-
Novartis Investigative Site
Madrid, 28009, Spain
-
Novartis Investigative Site
Madrid, 28040, Spain
-
Novartis Investigative Site
Málaga, 29016, Spain
-
Novartis Investigative Site
Seville, 41009, Spain
-
Novartis Investigative Site
Valencia, 46026, Spain
-
Novartis Investigative Site
Stockholm, 102 35, Sweden
-
Novartis Investigative Site
Samsun, Atakum, 55200, Turkey (Türkiye)
-
Novartis Investigative Site
Izmir, Balcova, 35340, Turkey (Türkiye)
-
Novartis Investigative Site
Istanbul, Fatih, 34093, Turkey (Türkiye)
-
Novartis Investigative Site
Istanbul, Fatih, 34098, Turkey (Türkiye)
-
Novartis Investigative Site
Izmir, Karabaglar, 35150, Turkey (Türkiye)
-
Novartis Investigative Site
Kayseri, Melikgazi, 38039, Turkey (Türkiye)
-
Novartis Investigative Site
Bursa, Nilufer, 16140, Turkey (Türkiye)
-
Novartis Investigative Site
Istanbul, Pendik, 34899, Turkey (Türkiye)
-
Novartis Investigative Site
Istanbul, Sancaktepe, 34785, Turkey (Türkiye)
-
Novartis Investigative Site
Kocaeli, 41380, Turkey (Türkiye)
-
Novartis Investigative Site
Konya, 42130, Turkey (Türkiye)
-
Novartis Investigative Site
Inverness, Invernesshire, IV2 3RE, United Kingdom
-
Novartis Investigative Site
Canterbury, Kent, CT1 3NG, United Kingdom
-
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
-
Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Piedmont HealthCare
Charlotte, North Carolina, 28210, United States
-
Premier Neurology
Greenville, South Carolina, 29605, United States
-
Regina Berkovich MD PhD Inc
West Hollywood, California, 90048, United States
-
Sibyl Wray MD Neurology PC
Knoxville, Tennessee, 37922, United States
-
South Shore Neurologic Associates
Patchogue, New York, 11772, United States
-
Texas Institute for Neurological Disorders
Sherman, Texas, 75092, United States
-
The Boster Ctr for MS
Columbus, Ohio, 43235, United States
-
True North Neurology
Port Jefferson, New York, 11776, United States
-
Tufts Medical Center
Boston, Massachusetts, 02111, United States
-
UM Department Of Neurology
Miami, Florida, 33136, United States
-
UT Health MARC Medical Arts and Research Center
San Antonio, Texas, 78229, United States
-
University Of NC At Chapel Hill
Chapel Hill, North Carolina, 27599 9500, United States
-
University of Florida
Gainesville, Florida, 32610, United States
-
University of Kansas Hospital
Kansas City, Kansas, 66160, United States
-
University of Washington MS Clinic
Seattle, Washington, 98133, United States
-
VA Greater LA Healthcare System
Los Angeles, California, 90073, United States
-
Vero Beach Neurology
Vero Beach, Florida, 32960, United States
-
Virginia Mason Medical Centre
Seattle, Washington, 98101, United States
-
Vladimir Royter MD APMC
Hanford, California, 93230, United States
Conditions
Explore the condition pages connected to this study.